Verruca Vulgaris
📧 Sign up to get email alerts when something new happens for Verruca Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Tirbanibulin for Pediatric Warts [Phase 4]
A Phase 4 clinical trial evaluating Tirbanibulin for treating hand warts in pediatric patients is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Cold Atmospheric Plasma Device Extension Study [Phase 3]
Phase 3 extension study of a cold atmospheric plasma device for verruca vulgaris and molluscum contagiosum was terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris) [Phase 3]
Phase 3 long-term follow-up study of cantharidin (YCANTH VP-102/TO-208) for common warts (verruca vulgaris) is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2) [Phase 3]
A Phase 3 clinical trial evaluating topical cantharidin (VP-102) for treatment of common warts (verruca vulgaris) is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart [NA]
A clinical trial is evaluating the topical combination of 5-fluorouracil and calcipotriol for palmoplantar warts in children. The study is c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Candin for the Treatment of Common Warts [Phase 3]
Phase 3 trial update reports that the Candin study for Verruca vulgaris (common warts) has completed.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts [Phase 2]
Phase 2 clinical trial evaluating Candida antigen and a bivalent HPV vaccine for treating multiple warts, sponsored by Zagazig University.
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts [Phase 2]
Phase 2 trial evaluating the safety and efficacy of the VDMN-21 Patch in subjects with verruca vulgaris (common warts) has completed, report…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in Warts
A completed clinical trial exploring whether interleukin-4 and interferon-gamma biomarkers predict responses to HPV immunotherapy in patient…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts at Tertiary Care Hospital in Karachi. [EARLY_Phase 1]
A Phase 1 study update on intralesional combined injection of furosemide and digoxin for treating cutaneous warts, currently enrolling by in…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts [NA]
A recruiting randomized controlled trial is evaluating the combination of hyperthermia and 3% hydrogen peroxide for treating cutaneous warts…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts
A completed clinical trial investigated gene expression of a suppressor of cytokines in cutaneous warts.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Intralesional Vitamin D Injection for Treatment of Common Warts [Phase 2]
A Phase 2 clinical trial evaluating intralesional vitamin D (cholecalciferol) injection for the treatment of common warts has completed, wit…
-
CLINICAL_TRIALS trial_result · 2024-04-05Clinical Trial Update: Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca [Phase 4]
Phase 4 clinical trial update on a cold atmospheric plasma device for pediatric verruca vulgaris and molluscum contagiosum; study completed …
-
FDA approval · 2023-07-21FDA Approved: YCANTH — Original Application (Verrica Pharmaceuticals Inc.)
FDA approved YCANTH (cantharidin) from Verrica Pharmaceuticals in an Original Application (NDA 212905) for the topical treatment of common w…
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: Cantharidin and Occlusion in Verruca Epithelium [Phase 2]
A Phase 2 study evaluating cantharidin with occlusion for verruca vulgaris (common warts) has completed and results were posted in September…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Topical 2% Povidone-Iodine Gel in Verruca Vulgaris [Phase 2]
A Phase 2 clinical trial update for topical 2% povidone-iodine gel targeting verruca vulgaris (warts).
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris) [Phase 2]
Phase 2 trial assessing varying regimens of CANDIN for common warts (verruca vulgaris) with completed status and posted results.
-
CLINICAL_TRIALS research · 2018-07-24Clinical Trial Update: Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts [Phase 3]
A Phase 3 clinical trial is comparing intralesional Candida antigen versus intralesional zinc sulfate for the treatment of verruca vulgaris …
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy [NA]
A clinical trial comparing pulsed 1064nm Nd:YAG laser treatment to liquid nitrogen cryotherapy for verruca vulgaris has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. [Phase 1]
Phase 1 exploratory study assessing safety and preliminary efficacy of 0.05% ingenol mebutate gel for verruca vulgaris (common warts) on the…
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population. [Phase 2]
Phase 2 trial of intralesional cidofovir for recalcitrant warts in immunosuppressed pediatric patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: ALC-919 For The Treatment Of Common Warts [Phase 2]
Phase 2 trial update showing completion of a study evaluating ALC-919 for the treatment of verruca vulgaris (common warts).
-
CLINICAL_TRIALS withdrawal · 2016-01-28Clinical Trial Update: The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s) [Phase 1]
A Phase 1 trial evaluating the safety of topical PEP005 for the treatment of common warts has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Oral Zinc Gluconate as Treatment for Recalcitrant Cutaneous Warts: A Randomized, Double-blind, Placebo-controlled Trial [Phase 2, Phase 3]
A randomized, double-blind, placebo-controlled trial evaluated oral zinc gluconate for recalcitrant cutaneous warts and has completed its Ph…